Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer’s disease: relevance for precision medicine in neurodegenerative diseases
Simone Lista, Andrea Vergallo, Stefan Teipel, et al.
Ageing Research Reviews (2022) Vol. 84, pp. 101819-101819
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Alzheimer's disease pathophysiology in the Retina
Bhakta Prasad Gaire, Yosef Koronyo, Dieu‐Trang Fuchs, et al.
Progress in Retinal and Eye Research (2024) Vol. 101, pp. 101273-101273
Open Access | Times Cited: 25
Exploitation of the multitarget role of new ferulic and gallic acid derivatives in oxidative stress-related Alzheimer's disease therapies: design, synthesis and bioevaluation
Fahad Hussain, Ayesha Tahir, Muhammad Saeed Jan, et al.
RSC Advances (2024) Vol. 14, Iss. 15, pp. 10304-10321
Open Access | Times Cited: 10
Discovery of pyrazoline analogs as multi-targeting cholinesterase, β-secretase and Aβ aggregation inhibitors through lead optimization strategy
Nilesh Gajanan Bajad, Jatin Jangra, T A Gajendra, et al.
International Journal of Biological Macromolecules (2025), pp. 140436-140436
Closed Access | Times Cited: 1
Astaxanthin nanoemulsion improves cognitive function and synaptic integrity in Streptozotocin-induced Alzheimer’s disease model
Mazzura Wan Chik, Meor Mohd Redzuan Meor Mohd Affandi, Nurul Aqmar Mohamad Nor Hazalin, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 3
Closed Access | Times Cited: 1
Lower oddball event-related EEG delta and theta responses in patients with dementia due to Parkinson's and Lewy body than Alzheimer's disease
Ebru Yıldırım, Tuba Aktürk, Lütfü Hanoğlu, et al.
Neurobiology of Aging (2024) Vol. 137, pp. 78-93
Closed Access | Times Cited: 7
Sulfur-fluoride exchange (SuFEx)-enabled lead discovery of AChE inhibitors by fragment linking strategies
Ziwen Zhang, Shilong Zhang, Chengyao Wu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115502-115502
Closed Access | Times Cited: 13
N-Methyl-D-Aspartate (NMDA) Receptor Antagonists and Their Pharmacological Implication: A Medicinal Chemistry-Oriented Perspective Outline
Vikas Rana, Shayantan Ghosh, Akanksha Bhatt, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 29, pp. 4725-4744
Closed Access | Times Cited: 4
Potential nanomedicinal applications and physicochemical nature of Hyphaene thebaica‐reduced nano‐samaria
Hamza Elsayed Ahmed Mohamed, Ali Talha Khalil, Khaoula Hkiri, et al.
Microscopy Research and Technique (2024) Vol. 87, Iss. 12, pp. 2829-2841
Closed Access | Times Cited: 4
In vitro and in vivo Investigations of 4-Substituted 2-Phenylquinazoline derivatives as multipotent ligands for the treatment of Alzheimer’s disease
Vijay Kumar, Kailash Jangid, Vishal Kumar, et al.
Bioorganic Chemistry (2025) Vol. 155, pp. 108126-108126
Closed Access
Biomarker Identification for Alzheimer’s Disease Using a Multi-Filter Gene Selection Approach
Elnaz Pashaei, Elham Pashaei, Nizamettin Aydın
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1816-1816
Open Access
Lancao decoction alleviates Alzheimer’s disease: depending on activating CaMKII to protect neuronal refunction by reducing β-amyloid in the hippocampus
Lei Wu, Yan Sun, Lingang Zhao, et al.
Journal of Ethnopharmacology (2025), pp. 119619-119619
Closed Access
Exploring Pyridinium-Based Inhibitors of Cholinesterases: A Review of Synthesis, Efficacy, and Structural Insights
Efraín Polo-Cuadrado, Rojas-Peña Cristian, A. Krogfelt Karen, et al.
European Journal of Medicinal Chemistry Reports (2025), pp. 100270-100270
Open Access
Vincamine, from an antioxidant and a cerebral vasodilator to its anticancer potential
Yulin Ren, Kevin DeRose, Leyan Li, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 92, pp. 117439-117439
Closed Access | Times Cited: 10
Essential Oils and Sustainability: In Vitro Bioactivity Screening of Myristica fragrans Houtt. Post-Distillation By-Products
Adriana Trifan, Gökhan Zengin, Izabela Korona‐Głowniak, et al.
Plants (2023) Vol. 12, Iss. 9, pp. 1741-1741
Open Access | Times Cited: 9
3D-QSAR-based pharmacophore modelling of quinazoline derivatives for the identification of acetylcholinesterase inhibitors through virtual screening, molecular docking, molecular dynamics and DFT studies
Vijay Kumar, Kailash Jangid, Naveen Kumar, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-15
Closed Access | Times Cited: 3
Hass Avocado (Persea americana Mill.) residues as a new potential source of neuroprotective compounds using pressurized liquid extraction
Juan F. Grisales-Mejía, Gerardo Álvarez‐Rivera, Harlen Torres, et al.
The Journal of Supercritical Fluids (2023) Vol. 204, pp. 106117-106117
Open Access | Times Cited: 8
The Intersection of Cerebral Cholesterol Metabolism and Alzheimer's Disease: Mechanisms and Therapeutic Prospects
Licheng Liu, Junyi Liang, Yanhong Liu, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30523-e30523
Open Access | Times Cited: 2
Autonomic nervous system flexibility for understanding brain aging
Feng Lin, Kathi L. Heffner
Ageing Research Reviews (2023) Vol. 90, pp. 102016-102016
Open Access | Times Cited: 4
Pistachio (Pistacia vera L.) consumption improves cognitive performance and mood in overweight young adults: A pilot study
Karina Landaverde-Mejia, Elisa Dufoo‐Hurtado, Diego Camacho-Vega, et al.
Food Chemistry (2024) Vol. 457, pp. 140211-140211
Closed Access | Times Cited: 1
Neuroimaging techniques, gene therapy, and gut microbiota: frontier advances and integrated applications in Alzheimer’s Disease research
Haitao Wang, Shi Chen, Ling Jiang, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 1
Turning the Spotlight to Cholinergic Pharmacotherapy of the Human Language System
Guadalupe Dávila, María José Torres‐Prioris, Diana López-Barroso, et al.
CNS Drugs (2023) Vol. 37, Iss. 7, pp. 599-637
Open Access | Times Cited: 3
Indoor environment regulation should consider personalization: Evidence from the evaluation of health effects in the kitchen
Hongwei Lou, Qinghong Liu, Huaguo Chen, et al.
Energy and Buildings (2023) Vol. 300, pp. 113641-113641
Closed Access | Times Cited: 2
Proanthocyanidins supplemented diet alter anti-aging-markers and improved lifespan in Drosophila melanogaster model
Mohammed Sani Jaafaru, Suleiman Alhaji Muhammad, Zainab Kasim Mohammed, et al.
Beni-Suef University Journal of Basic and Applied Sciences (2024) Vol. 13, Iss. 1
Open Access
Factors associated with cognitive function in patient with Alzheimer's disease with newly prescribed acetylcholinesterase inhibitors: A 1‐year retrospective cohort study
Pao‐Yuan Ching, Cheng‐Ho Chang, Chih‐Chuan Pan, et al.
Aging Medicine (2024) Vol. 7, Iss. 3, pp. 312-319
Open Access
Research progress on the mechanisms, assessment methods, and intervention strategies for glioma-related cognitive impairment
Riffat Iqbal, Zeeshan Ashraf
Asia-Pacific Journal of Oncology (2024)
Open Access
Page 1 - Next Page

Scroll to top